Table 2.

Clinical data from hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) patients enrolled in this study. Number of patients and frequencies (%) are indicated

		CCA N = 8	HCC N = 20
TNM	Stage I	1 (13%)	3 (15%)
	Stage II	4 (50%)	15 (75%)
	Stage IIIA	0 (0%)	1 (5%)
	Stage IV	3 (38%)	1 (5%)
Histologic grade (G)	G1	2 (25%)	2 (10%)
	G2	3 (38%)	11 (55%)
	G3	3 (38%)	6 (30%)
	G4	0 (0%)	1 (5%)
HBsAg	Positive	0 (0%)	1 (5%)
HCV	Positive	0 (0%)	6 (30%)
Vascular microinvasion	Positive	–	8 (40%)
Cirrhosis		0 (0%)	15 (75%)
Relapse		3 (38%)	1 (5%)
Death		3 (38%)	2 (10%)
Liver Transplant		0 (0%)	7 (35%)